Compile Data Set for Download or QSAR
maximum 50k data
Found 31 Enz. Inhib. hit(s) with all data for entry = 3138
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392710(Example 4 | US10301291, Compound 10d)
Affinity DataIC50: <30nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392734(Example 34 | US10301291, Compound 15d)
Affinity DataIC50: <30nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392737(Example 37 | US10301291, Compound 15g)
Affinity DataIC50: <30nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392728(Example 28 | US10301291, Compound 14d)
Affinity DataIC50: <30nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392733(Example 33 | US10301291, Compound 15c)
Affinity DataIC50: <30nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392717(Example 11 | US10301291, Compound 11e)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392716(Example 10 | US10301291, Compound 11d)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392712(Example 6 | US10301291, Compound 10f)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392711(Example 5 | US10301291, Compound 10e)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392709(Example 3 | US10301291, Compound 10c)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392707(Example 1 | US10301291, Compound 10a)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392722(Example 16 | US10301291, Compound 12d)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392736(Example 36 | US10301291, Compound 15f)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392735(Example 35 | US10301291, Compound 15e)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392732(Example 32 | US10301291, Compound 15b)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392731(Example 31 | US10301291, Compound 15a)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392730(Example 30 | US10301291, Compound 14f)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392719(Example 13 | US10301291, Compound 12a)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392720(Example 14 | US10301291, Compound 12b)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392721(Example 15 | US10301291, Compound 12c)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392723(Example 17 | US10301291, Compound 12e)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392724(Example 18 | US10301291, Compound 12f)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392726(Example 26 | US10301291, Compound 14b)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392727(Example 27 | US10301291, Compound 14c)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392729(Example 29 | US10301291, Compound 14e)
Affinity DataIC50:  65nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392708(Example 2 | US10301291, Compound 10b)
Affinity DataIC50: >100nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392715(Example 9 | US10301291, Compound 11c)
Affinity DataIC50: >100nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392713(Example 7 | US10301291, Compound 11a)
Affinity DataIC50: >100nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392725(Example 25 | US10301291, Compound 14a)
Affinity DataIC50: >100nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392714(Example 8 | US10301291, Compound 11b)
Affinity DataIC50: >100nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
Samjin Pharmaceutical

US Patent
LigandPNGBDBM392718(Example 12 | US10301291, Compound 11f)
Affinity DataIC50: >100nMAssay Description:First of all, after a substrate was inserted into a prepared base reaction buffer solution (20 mM Hepes (pH 75), 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent